🔎 Trials Near Me

Akèy › Adenokasinom Ezofajyen › Ohio › Cleveland

Etid klinik pou Adenokasinom Ezofajyen nan Cleveland, OH

7 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma

Ap rekriteFaz 2
  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06044311

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

Ap rekriteVolontè an sante akeyi
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic Taussig Cancer Center, Cleveland
Laj 50 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06687603

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

Ap rekriteFaz 2
  • Case Western Reserve University, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06732388

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Ap rekrite
  • Cleveland VA Medical Research and Education Foundation, Cleveland
  • University Hospitals Cleveland Medical Center Case Western University, Cleveland
  • Cleveland Clinic Foundation, Cleveland
Laj 18 a 89 · Tout sèks · Mizajou Sep 11, 2026 · NCT05753748

Obeticholic Acid for Prevention in Barrett's Esophagus

Ap rekriteFaz 2
  • Case Western Reserve University, Cleveland
  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland
  • University Hospitals Cleveland Medical Center, Cleveland
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT04939051

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • Research Site, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT07284186

Etid Adenokasinom Ezofajyen nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.